glp-1 and dual glp-1/gip receptor agonists This review summarizes how GIP/GLP-1 act at the cellular level and their therapeutic applications in metabolic diseases like type 2 diabetes and obesity, highlighting advances in incretin-based Frontiers | Clinical perspectives on
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5



























![Brand [Urza's Saga] DP53](https://cdn.shopify.com/s/files/1/0561/0376/4010/files/bafbd034-c8a0-4798-a680-555c13bdd251_04579b47-65f8-4c56-85c4-7fee410c6b75.png?v=1771703974)
